Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Trillions of SNPs Versus a Glass of Grappa

David S. Pisetsky, MD  |  Issue: April 2011  |  April 13, 2011

After-dinner grappa.
After-dinner grappa.
David S. Pisetsky, MD

At a meeting I attended recently, I heard a series of dazzling talks on human genetics. The meeting was held in a venerable and majestic city in Europe, but the venue was a modern hotel near the airport. Unlike some European hotels that provide only one towel—a veritable washcloth—this place was downright American in the luxuriousness of the drying equipment. Three large expanses of fluffy white cotton along with hand towels and bars of free soap decorated my bathroom. Apparently, the Green Revolution must be meeting stiff opposition as the once Spartan hotels of old Europe are getting Hiltonesque to meet the demands of travelers who want their towels smelling clean and daisy fresh no matter how much laundry detergent pours into the Rhine, Seine, or Danube.

The talks at the meeting described the striking progress in unraveling the genetics of autoimmune disease. Because of advances in chip technology and bioinformatics, new analytic platforms can assess thousands and millions of snips (SNPs or single-nucleotide polymorphisms) in days (Hours? Minutes?) for the price of pennies. The visionaries in the genetic avant garde claim that it will soon be possible to obtain a person’s full genome sequence for a thousand dollars.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I do not doubt the power of the technology, although I am skeptical about the business model. After all, the charge for a uric acid test was only a few bucks, and this very useful test was dropped from multiphasic screening because it was not considered cost effective. Knowing the powers that be in the business office, I suspect that the cost of a gene screen will skyrocket, especially if each SNP is billed separately for over the 20,000 genes that can be currently assessed.

Along with the boost in the extent of SNP testing, current research demands studies of an ever larger number of patients, with one study presented at the conference involving 100,000 patients to analyze the genetic determinants of height. The magnitude of these studies should not be surprising. Most (perhaps all) human traits are very complex and involve multiple genes and gene–gene interactions of dizzying complexity. Sorting out these patterns will be a heroic effort because of the enormous genetic variation in the population. With the mixing and matching that goes on in the mysterious pairings in human reproduction, genetic studies in the future will involve, to paraphrase the late Carl Sagan, billions and billions of data points.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out RheumTechnology Tagged with:geneticsResearchrheumatologistTechnology

Related Articles

    A Unique Structure for Tackling Psoriatic Disease

    June 13, 2011

    GRAPPA brings together a group of highly motivated physicians to address these complex disorders

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

    Gene Manipulation Has Potential to Alter Genomes, Impact Society

    Gene Manipulation Has Potential to Alter Genomes, Impact Society

    January 19, 2016

    Every so often, a major scientific breakthrough profoundly alters the trajectory of scientific research. In the 1960s, microbiologists sparked the recombinant-DNA revolution with the discovery that bacteria have innate immune systems based on restriction enzymes. These enzymes bind and cut invading viral genomes at specific short sequences, and scientists rapidly repurposed them to cut and…

    Genome-Wide Association Studies of SLE

    February 12, 2011

    What do these studies tell us about disease mechanisms in lupus?

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences